Mesenchymal stromal cells (MSCs) possess numerous regenerative and immune modulating functions. Transplantation across histocompatibility barriers is feasible due to their hypoimmunogenicity. MSCs have emerged as promising tools for treating graft-versus-host disease following allogeneic stem cell transplantation. It is well established that their clinical efficacy is substantially attributed to fine-tuning of T-cell responses. At the same time, increasing evidence suggests that metabolic processes control T-cell function and fate. Here, we investigated the MSCs' impact on the metabolic framework of activated T-cells. In fact, MSCs led to mitigated mTOR signaling. This phenomenon was accompanied by a weaker glycolytic response (including glucose uptake, glycolytic rate, and upregulation of glycolytic machinery) toward T-cell activating stimuli. Notably, MSCs express indoleamine-2,3-dioxygenase (IDO), which mediates T-cell suppressive tryptophan catabolism. Our observations suggest that IDO-induced tryptophan depletion interferes with a tryptophan-sufficiency signal that promotes cellular mTOR activation. Despite an immediate suppression of T-cell responses, MSCs foster a metabolically quiescent T-cell phenotype characterized by reduced mTOR signaling and glycolysis, increased autophagy, and lower oxidative stress levels. In fact, those features have previously been shown to promote generation of long-lived memory cells and it remains to be elucidated how MSC-induced metabolic effects shape in vivo T-cell immunity. STEM CELLS 2016;34:516-521 
INTRODUCTION
Adoptive transfer of mesenchymal stromal cells (MSCs) has emerged as a promising option for treating particularly acute forms of graft-versus-host disease (GvHD) following allogeneic stem cell transplantation [1] . Multipotent MSCs hold several advantageous features including easy extraction and expansion, a relative immune privilege that allows transplantation over immune barriers, and a plethora of immune-modulating mechanisms involving cell-to-cell contact, soluble factors, and induction of suppressive cell phenotypes [2, 3] . As yet, no toxic effects have been reported and despite a well-established T-cell modulatory activity [4] [5] [6] , MSC-treated patients do not experience an increased risk for disease relapse or infectious complications [7, 8] .
Increasing evidence highlights the significance of metabolic processes in controlling T-cell activation, differentiation, and memory formation [9] . Following antigen encounter, T-cells shift towards aerobic glycolysis for acquiring effector functions while memory and regulatory T-cells (T Regs ) utilize mainly oxidative phosphorylation (OXPHOS) for meeting energetic demands. Remarkably, interference within the metabolic framework allows controlling T-cell fate as exemplified by studies showing that blocking glycolysis hampers effector functions and promotes development of long-lived memory Tcells [10] [11] [12] [13] .
As yet, it remains unknown whether MSCs interfere with T-cell metabolism. Therefore, we sought out to investigate the MSCs' impact on metabolic signaling in activated T-cells.
METHODS

Cells
T-cells were purified by magnetic bead-based selection (T-cell Isolation Kit II and Effector Memory T-cell Isolation Kit, Miltenyi Biotec, Bergisch Gladbach, Germany). MSCs were isolated from iliac crest bone marrow aspirates from healthy donors (approval number: 200_12), expanded as previously detailed while fulfilling uniformly minimal MSC criteria [3] .
Coculture Experiments
MSC and T-cell cocultures were performed for 72 hours as previously detailed [6] . In selected experiments rapamycin (Sigma Aldrich, St. Louis, MO, USA), 1-methyl-DL-tryptophan (1-MT, Sigma-Aldrich), DL-tryptophan (Sigma-Aldrich) was applied.
Adenosine 5 0 -triphosphate Levels Adenosine 5 0 -triphosphate (ATP) was assessed using a colorimetric ATP Assay Kit (Abcam, Cambridge, UK).
Flow Cytometry
Cells were stained following the manufacturers' recommendations using fluorochrome-coupled antibodies (Supporting Information Table 1 ) and/or chemical dyes. Cells were analyzed using a FACS Canto II cytometer (BD Biosciences, Franklin Lakes, NJ, USA) and the FlowJo Version 9.5 software (TreeStar, Ashland, OR, USA).
DNA, RNA preparation, and Quantitative Polymerase Chain Reaction
RNA/DNA were extracted from cell lysates (RNeasy Mini Kit, Qiagen, Hilden, Germany) and cDNA prepared (Superscript First Strand Synthesis System, Life Technologies, Carlsbad, CA, USA) using a Mastercycler Nexus (Eppendorf, Hamburg, Germany). The messenger RNA (mRNA) levels were quantified by quantitative polymerase chain reaction (qPCR; Quantitect SYBR Green PCR Kit; Qiagen) on a Rotor Gene Q (Qiagen). Relative gene expression was determined by normalizing expression of target genes (Supporting Information Table 2) to bactin.
Extracellular Flux Analysis
Bioenergetics were determined using an XFe96 Extracellular Flux Analyzer (Seahorse Bioscience, North Billerica, MA, USA) as previously described [14] .
Fluorescence Microscopy
Autophagy was visualized using an LC3 antibody (Merck Millipore, Billerica, MA, USA) and DAPI (Sigma Aldrich) for nuclear counter staining. Analysis was performed on a fluorescence microscope (Axio-Imager M2, Zeiss, Jena, Germany) at 630 3 magnification using the AxioVision Software (Zeiss).
Statistical Analyses
Differences in means of continuous variables were evaluated using a paired t-test if not stated otherwise. All statistical analyses were performed using GraphPad Prism Version five 
RESULTS AND DISCUSSION
Metabolism critically controls T-cell function and fate [9] . Triggering T-cell and CD28 co-stimulatory receptors elicits a marked glycolytic shift ( Fig. 1A , Supporting Information Fig.  1 ). This metabolic switch is facilitated by upregulation of glycolytic molecules including hexokinase-1/2, lactate dehydrogenase, and glyceraldehyde-3-phosphate dehydrogenase, increased expression of glucose transporters promoting glucose uptake ( Fig. 1B and C, Supporting Information Fig. 2) , and as previously shown [15] mechanistic target of rapamycin (mTOR) signaling ( Fig. 1D ). Blocking aerobic glycolysis abrogates T-cell activation (Supporting Information Fig. 3 ). At the same time expression of carnitine-palmitoyl-transferase-1 a rate-limiter for fatty acid oxidation (FAO) declines [11] and proportion of FAO-dependent OXPHOS (and ATP-production) accordingly decreases ( Fig. 1E and F) .
Since MSCs display a high density of glucose transporters, a substantial glucose influx, and perform aerobic glycolysis (Supporting Information Fig. 4 ), we were interested whether MSCs interfere with T-cell activation through substrate competition in analogy to the concept of T Regs controlling T-cell responses via IL-2 restriction [16] . In fact, glucose availability had no impact on MSCs' suppressive activity (Supporting Information Fig. 5 ).
MSCs significantly interfered with mTOR signaling, paralleled by reduced upregulation of glycolytic enzymes and glucose uptake mimicking effects of mTOR inhibitors ( Fig. 2A -C, Supporting Information Figs. [6] [7] [8] [9] [10] . This is in line with ex vivo and in vitro observations regarding MSC-related T Reg induction [5, 6] , which can also be achieved by pharmacological mTOR inhibition [17] . The T-cells' overall metabolic turnover was reduced as implicated by lower ATP and OXPHOS levels (Fig.  2D, Supporting Information Fig. 11 ). Mitochondrial fitness as , in response to glucose ( 5 baseline glycolysis) and upon blocking the mitochondrial ATP generation by oligomycin. The resulting (compensatory) effect on ECAR following interference with mitochondrial energy metabolism represents the cells' maximal glycolytic capacity. (D) ATP levels were determined in lysates from T-cells cultured for three days under the indicated conditions (n 5 5). (E) The OCR/ECAR ratio indicative for the energetic balance between OXPHOS and aerobic glycolysis was calculated for T-cells activated for 3 days in presence or absence of MSCs (n 5 4). (F) Changes in the relative gene expression (mRNA) of carnitine-palmitoyl-transferase-1 (cpt1a) were determined by quantitative PCR in T-cells (n 5 6) stimulated in presence of MSCs for three days as compared to stimulated T-cells alone (set as 1). A paired t-test was used for data analysis. Bars indicate the standard error of the mean. *, p < 0.05; **, p < 0.005; ***, p < 0.001. Abbreviations: ATP, adenosine 5 0 -triphosphate; ECAR, extracellular acidification rate; MFI, median fluorescence index; mRNA, messenger RNA; MSC, mesenchymal stromal cells; mTOR, mechanistic target of rapamycin; pmTOR, phosphorylated mTOR; OCR, oxygen consumption rate.
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MSCs Act as a Metabolic Checkpoint for T-Cells V C AlphaMed Press 2015 indicated by the ability to generate and sustain an electrochemical gradient ( 5 DWM) was not affected (Supporting Information Fig. 12 ). However, when analyzing the ratio between oxygen consumption rate (OCR, indicative for OXPHOS) and extracellular acidification rate (ECAR, indicative for aerobic glycolysis) we noticed an MSC-related skewing toward OCR suggesting a shift of energetic balance ( Fig. 2E ). This effect is additionally resembled by pharmacological mTOR inhibition (Supporting Information Fig. 13) [10] and further corroborated by findings that MSCs preserve carnitinepalmitoyl-transferase-1 (cpt1a) expression ( Fig. 2F) [18] .
Next, we tested whether MSC-mediated metabolic effects last upon MSC removal. T-cells previously activated in presence of MSCs retain reduced proliferative capacity (Supporting Information Fig. 14) , mTOR responsiveness, glucose influx, and aerobic glycolysis ( Fig. 3A and B) . As anticipated, glycolytic molecules were not adequately upregulated (Supplemental Fig. 15 ). In view of a so-called epigenetic memory that is formed in activated T-cells, [19] the MSCs' impact on it remains to be elucidated.
Within its role as a metabolic master-regulator mTOR integrates nutrient sensing pathways [20] . Deprivation of amino acids causes mTOR inactivation ( Fig. 2A) leading to autophagy via LC3 de-repression ( Fig. 3C, Supporting Information Fig.  16 ), translational blockade via S6K inactivation ( Fig. 2A) , and inhibition of aerobic glycolysis (Fig. 2C) [21] . Recently, it was shown that tryptophan-depleting IDO disrupts a tryptophan sufficiency signal that stimulates mTOR [22] . MSCs employ among other mechanisms IDO for regulating T-cell responses [2, 4, 6] (Supporting Information Fig. 17 ). Tryptophan supplementation and IDO inhibition by 1-MT acting as a tryptophan mimetic [22] sustained activated T-cells' mTOR signaling together with increased glucose uptake and glycolytic capacities ( Fig. 3D and E, Supporting Information Fig. 18 ).
Recent evidence indicates that mTOR inhibition [12, 13] , disrupting glycolysis [11] , and inducing autophagy (Fig. 3C ) Figure 3 . Metabolic T-cell perturbation is sustained upon MSC removal and is facilitated by tryptophan depletion. T-cells were treated with activating anti-CD2/-CD3/-CD28 antibodies for three days in the presence or absence of third-party MSCs. Following MSC removal T-cells alone were re-stimulated for three more days ( 5 MSCs*). We (semi-)quantified in T-cells (A) mTOR activation based on the median fluorescence index (MFI) of phosphorylated (active) mTOR (pmTOR), the (B) glucose uptake (n 5 4) based on the MFI of the incorporated fluorescent glucose analog NBDG, and the lactic acid produced during aerobic glycolysis in the culture supernatants (n 5 4). (C) Autophagy was visualized by fluorescence microscopy in T-cells stimulated for three days in the presence or absence of MSCs using LC3 antibodies (green). Samples were counterstained with the vital nuclear dye DAPI (blue). Illustration is representative for six independent experiments. (D) T-cells were stimulated in the presence or absence of MSCs for 72 hours together with 1 mM 1-MT or 500 lM tryptophan as indicated. Activation of the mTOR pathway was assessed based on the phosphorylation levels of its downstream molecule pS6K1 (n 5 5). Glucose uptake was evaluated as shown in a representative (for three independent experiments) FACS analysis based on NBDG MFI. (E) T-cells were stimulated in the presence or absence of MSCs for 72 hours with/without 1-MT (n 5 4). ECAR as a surrogate for aerobic glycolysis was measured using an XFe96 flux analyzer upon addition of glucose (gluc) ( 5 basal glycolysis) and upon blocking mitochondrial metabolism with 1 lM oligomycin (oligo) ( 5 glycolytic capacity). The reaction was terminated using 100 mM 2-DG. A paired t-test was used for data analysis. Bars indicate the standard error of the mean. *, p < 0.05; **, p < 0.005; ***, p < 0.001. Abbreviations: 2-DG, 2-deoxy-D-glucose; ECAR, extracellular acidification rate; FITC, fluorescein isothiocyanate; MFI, median fluorescence index; MSC, mesenchymal stromal cells; NBDG, N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose; pmTOR, phosphorylated mTOR; OCR, oxygen consumption rate. 519 www.StemCells.com V C AlphaMed Press 2015 [23] positively impact T-cells' durability and memory cell formation. Accordingly, T-cells activated in presence of MSCs expressed more CD62L and genes linked to memory response ( Fig. 4A and B) [11, 12] . Furthermore, cellular oxidative stress levels are reduced together with increased thiol content, upregulation of antioxidants ( Fig. 4C-E) , and reduced mitochondrial oxidative stress (Supporting Information Fig. 19 ). These phenomena have been previously reported in context of mTOR inhibition and metabolic quiescence [11, 12, 24] . Frequency of total memory T-cells remained unchanged except some subset shifts involving central and effector memory T-cells ( Fig. 4F, Supporting Information Fig. 20 ). However, MSCs had no numerical impact on induction of central memory cells from purified effector memory T-cells whereas CD62L expression was significantly promoted (Fig. 4G ).
CONCLUSIONS
Taken together, MSCs impact the metabolic phenotype of activated T-cells [9] . The rapid increase of glycolysis is a prerequisite for proper T-cell activation. Therefore, MSC-mediated perturbation of mTOR signaling-a key regulator of glycolytic metabolism [20] -is in keeping with the T-cell suppressive activity of MSCs [4] . However, several of the MSC-mediated metabolic effects including mTOR inhibition [10, 12, 13] , reduced glycolysis [11] , and promotion of autophagy [23] are linked to memory formation and longevity in T-cells. These findings certainly require further exploitation especially in view of ongoing discussions regarding the risk for disease relapse and/or infectious complications upon adoptive MSC transfer in GvHD patients [7, 8] . Furthermore, combining pharmacological mTOR inhibition [25] and MSC-transfer might represent a promising strategy for merging their beneficial (metabolic) effects on T-cells in an additive fashion. 
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